T1	p 23 29	asthma
T2	p 33 39	adults
T3	p 230 260	31 adult asthmatic patients in
T4	i 46 87	sodium cromoglycate pressurized aerosol :
T5	i 122 212	Sodium cromoglycate formulated as a pressurized aerosol ( 2 mg 4-times daily ) and placebo
T6	i 311 330	Sodium cromoglycate
T7	i 347 354	placebo
T8	i 776 788	cromoglycate
T9	i 811 880	bronchodilators ( theophylline and aerosol beta-stimulants combined )
T10	i 940 952	cromoglycate
T11	i 975 982	placebo
T12	i 1053 1105	sodium cromoglycate delivered by pressurized aerosol
T13	i 1136 1143	placebo
T14	o 358 390	improving breathlessness at rest
T15	o 415 441	breathlessness on exertion
T16	o 471 487	quality of sleep
T17	o 538 577	morning peak expiratory flow rate value
T18	o 988 1000	side-effects
T19	o 1168 1186	asthmatic symptoms